ATF2 acts as an important oncogene in prostate cancer, melanoma, non-small cell lung carcinoma and pancreatic cancer [23–26], while ATF2 exhibits tumor suppressor functions in nonmalignant skin and breast cancer [23, 27], suggesting a context-dependent role for ATF2 in cancer biology. This evidence concerns the gene ATF2 and breast carcinoma.